Mitsuo Otsuka

1.4k total citations · 1 hit paper
43 papers, 979 citations indexed

About

Mitsuo Otsuka is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Mitsuo Otsuka has authored 43 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 6 papers in Surgery. Recurrent topics in Mitsuo Otsuka's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Neonatal Respiratory Health Research (7 papers). Mitsuo Otsuka is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Neonatal Respiratory Health Research (7 papers). Mitsuo Otsuka collaborates with scholars based in Japan, Germany and Ireland. Mitsuo Otsuka's co-authors include Hirofumi Chiba, Hiroki Takahashi, Koji Kuronuma, Mitsuru Mori, Yukihiko Sugiyama, Kazumi Kudo, Masashi Bando, Gen Yamada, Kimiyuki Ikeda and Hirotaka Nishikiori and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Oncogene.

In The Last Decade

Mitsuo Otsuka

41 papers receiving 967 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences

2014 350 citations Hirofumi Chiba, Koji Kuronuma et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Mitsuo Otsuka

Since Specialization

Citations

This map shows the geographic impact of Mitsuo Otsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Otsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Otsuka more than expected).

Fields of papers citing papers by Mitsuo Otsuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuo Otsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Otsuka. The network helps show where Mitsuo Otsuka may publish in the future.

Co-authorship network of co-authors of Mitsuo Otsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuo Otsuka. A scholar is included among the top collaborators of Mitsuo Otsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuo Otsuka. Mitsuo Otsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Case of Repeated Cytokine Releasing Syndrome During Nivolumab Plus Ipilimumab Therapy, with Bacterial Infection Suspected as a Trigger for Relapse 2025 ·Haigan ·(unknown), Toshiyuki Sumi, (unknown), Kazuhiro Kamada, (unknown), Mitsuo Otsuka, (unknown), Takumi Ikeda, (unknown), Hirofumi Chiba	0
2	Nationwide Questionnaire-based Survey on Methods for Performing Bronchoalveolar Lavage 2024 ·Takeshi Isobe, Atsushi Miyamoto, Yuko Waseda, Yukari Tsubata, Mitsuo Otsuka, Manabu Ishida, Yasushi Horimasu, Shin‐ichi Nureki, (unknown), Noriaki Kurimoto, Hiroki Takahashi, Haruyuki Ishii	0
3	Development of a new HISCL automated CXCL9 immunoassay 2023 ·Scientific Reports ·Takehiro Hasegawa, (unknown), Shunsuke Watanabe, (unknown), Hideo Asada, Atsushi Nakagawa, Keisuke Tomii, (unknown), Mitsuo Otsuka, Koji Kuronuma, Hirofumi Chiba, (unknown), Yasunari Miyazaki, Akio Mori	3
4	Prognostic value of 6-min walk stress echocardiography in patients with interstitial lung disease 2021 ·Journal of Echocardiography ·Kenji Yasui, Satoshi Yuda, Kiyoshi Abe, (unknown), (unknown), Yuta Sudo, Kimiyuki Ikeda, Atsuko Muranaka, Mitsuo Otsuka, Daigo Nagahara, Hirofumi Ohnishi, Hiroki Takahashi, Tetsuji Miura, Satoshi Takahashi	1
5	Thymic Adenocarcinoma with Positivity for Thyroid Transcription Factor-1 and a BRAF V600E Mutation 2021 ·Internal Medicine ·(unknown), Mitsuo Otsuka, Shin Ichihara, (unknown), (unknown), Tomoyuki Takahashi, Masaki Mori, (unknown), Hirofumi Chiba	1
6	Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis 2020 ·BMC Pulmonary Medicine ·(unknown), Mitsuo Otsuka, Hirofumi Chiba, Kimiyuki Ikeda, Yuki Mori, (unknown), Hirotaka Nishikiori, Koji Kuronuma, Hiroki Takahashi	34
7	Insufficient serum L-ficolin is associated with disease presence and extent of pulmonary Mycobacterium avium complex disease 2019 ·Respiratory Research ·(unknown), Koji Kuronuma, Atsushi Saito, Kimiyuki Ikeda, Shigeru Ariki, (unknown), Mitsuo Otsuka, Hirofumi Chiba, Satoshi Takahashi, Motoko Takahashi, Hiroki Takahashi	9
8	Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment 2018 ·Vaccine ·Koji Kuronuma, Hiroyuki Honda, (unknown), Atsushi Saito, Kimiyuki Ikeda, Mitsuo Otsuka, Hirofumi Chiba, Gen Yamada, Toyotaka Sato, Shin‐ichi Yokota, Hiroki Takahashi	6
9	Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review 2018 ·Respiratory Investigation ·Hirofumi Chiba, Mitsuo Otsuka, Hiroki Takahashi	38
10	Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients 2017 ·Oncogene ·(unknown), Yoshihiro Hasegawa, Mitsuo Otsuka, Shigeru Ariki, Rina Takamiya, Atsushi Saito, (unknown), Hiroshi Saijo, Koji Kuronuma, Hirofumi Chiba, Hirofumi Ohnishi, Yuji Sakuma, Hiroki Takahashi, Y. Kuroki, Motoko Takahashi	27
11	Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone 2017 ·Kimiyuki Ikeda, Masanori Shiratori, Hirotaka Nishikiori, (unknown), (unknown), (unknown), Atsushi Saito, Koji Kuronuma, Mitsuo Otsuka, Hirofumi Chiba, Gen Yamada, Hiroki Takahashi, Mamoru Takahashi	1
12	Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone 2017 ·Respiratory Medicine ·Kimiyuki Ikeda, Masanori Shiratori, Hirofumi Chiba, Hirotaka Nishikiori, (unknown), Atsushi Saito, Yoshihiro Hasegawa, Koji Kuronuma, Mitsuo Otsuka, Gen Yamada, Hiroki Takahashi	20
13	Serial Measurements of Tricuspid Regurgitation Pressure Gradient by Echocardiography Predict Prognosis In Idiopathic Pulmonary Fibrosis 2016 ·Yasuo Kitamura, Mitsuo Otsuka, Gen Yamada, Satoshi Yuda, (unknown), Kimiyuki Ikeda, Koji Kuronuma, Hirofumi Chiba, Akiyoshi Hashimoto, Hiroki Takahashi	1
14	Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis 2016 ·Respiratory Investigation ·(unknown), Hirofumi Chiba, Hirotaka Nishikiori, (unknown), Koji Kuronuma, Mitsuo Otsuka, Gen Yamada, Hirofumi Ohnishi, Mitsuru Mori, Yasuhiro Kondoh, Hiroyuki Taniguchi, Sakae Homma, Hiroki Takahashi	31
15	Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis 2016 ·Laboratory Investigation ·Miki Yamaguchi, Sachie Hirai, Yusuke Tanaka, Toshiyuki Sumi, Masahiro Miyajima, (unknown), Gen Yamada, Mitsuo Otsuka, Tadashi Hasegawa, Takashi Kojima, Toshiro Niki, Atsushi Watanabe, Hiroki Takahashi, Yuji Sakuma	60
16	Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences breakdown → 2014 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi	350
17	Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis 2014 ·BMC Pulmonary Medicine ·Hirotaka Nishikiori, Hirofumi Chiba, Shigeru Ariki, Koji Kuronuma, Mitsuo Otsuka, Masanori Shiratori, Kimiyuki Ikeda, Atsushi Watanabe, Yoshio Kuroki, Hiroki Takahashi	30
18	Development of an enzyme-linked immunosorbent assay for measurement of rat pulmonary surfactant protein D using monoclonal antibodies 2010 ·Experimental Lung Research ·Makoto Murata, Mitsuo Otsuka, Hiromi Mizuno, Masanori Shiratori, Shuichi Miyazaki, Hisato Nagae, S. Kanazawa, Masaru Hamaoki, Yoshio Kuroki, Hiroki Takahashi	6
19	Decreased Subepithelial Microvasculature Observed by High Magnification Bronchovideoscope in the Large Airways of Smokers 2008 ·Internal Medicine ·Gen Yamada, Noriharu Shijubo, (unknown), Mamoru Takahashi, Mitsuo Otsuka, Masaru Fujii, Hiroki Takahashi	5
20	Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist 2003 ·Thorax ·Mitsuo Otsuka	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact